Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

balance of clinical and cost-eff ectiveness. Azathioprine is not recommended due to its SE profi le. Treating relapses: Methylprednisolone, eg 0.5–1g/24h IV/PO for 3–5d shortens acute relapses; use sparingly ( twice/yr; steroid SE, p377). It doesn’t alter overall prognosis. Symptom control: Spasticity: off er baclofen or gabapentin. Tizanidine or dant- rolene are 2nd line; if these fail consider benzodiazepines. Tremor: botulinum toxin type A injections improve arm tremor and functioning . Urgency/frequency: if post- micturition residual urine >100mL, teach intermittent self-catheterization; if <100mL, try tolterodine. Fatigue: amantadine, CBT, and exercise may help. __OOHHCCMM__1100ee..iinnddbb 449966 0022//0055//22001177 1199::0088 ygolorueN Table 10.8 Clinical features of MS 497 Sensory: • Dysaesthesia GI: Swallowing disorders; constipation. • Pins and needles Eye: Diplopia; hemianopia; optic neuritis; visual • Vibration sense phe nomena (eg on exercise); bilateral intern uclear • Trigeminal neuralgia ophthalmoplegia (p73); pupil defects. Motor: • Spastic weakness Cerebellum: Trunk and limb ataxia; intention • Myelitis trem or; scanning (ie monotonous) speech; falls. Sexual/GU: • Erectile dysfunction Cognitive/visuospatial decline: A big cause • Anorgasmia; urine of un employment, accidents, amnesia, mood, ret ention; inconti- executive functioning. nence NB T°, malaise, nausea, vomiting, positional vertigo, seizures, aphasia, meningism, bilateral optic neuritis, CSF leucocytosis and CSF protein
